Results 101 to 110 of about 604,319 (313)

Computational modeling of in-stent restenosis: Pharmacokinetic and pharmacodynamic evaluation [PDF]

open access: yesarXiv, 2023
Persistence of the pathology of in-stent restenosis even with the advent of drug-eluting stents warrants the development of highly resolved in silico models. These computational models assist in gaining insights into the transient biochemical and cellular mechanisms involved and thereby optimize the stent implantation parameters.
arxiv  

Clinical Impact of Intravascular Ultrasound–Guided Chronic Total Occlusion Intervention With Zotarolimus-Eluting Versus Biolimus-Eluting Stent Implantation: Randomized Study

open access: yesCirculation. Cardiovascular Interventions, 2015
Background—There have been no randomized studies comparing intravascular ultrasound (IVUS)–guided versus conventional angiography–guided chronic total occlusion (CTO) intervention using new-generation drug-eluting stent Therefore, we conducted a ...
Byeong‐Keuk Kim   +13 more
semanticscholar   +1 more source

Time to reperfusion in high-risk patients with myocardial infarction undergoing primary percutaneous coronary intervention

open access: yesRevista Portuguesa de Cardiologia, 2019
Introduction: Timely reperfusion with primary percutaneous coronary intervention (PPCI) in ST-segment elevation myocardial infarction (STEMI) improves patient outcomes.
Rita Calé   +4 more
doaj  

Trackability Measurement of Coronary Stent in a Coronary Vessel Modell [PDF]

open access: yes, 2008
The EN 14299 standard describes in vitro tests of stent and stent system which are specified more precisely and cover a number of additional parameters.
Dobránszky, János, Szabadíts, Péter
core  

Pharmacokinetic analysis after implantation of everolimus-eluting self-expanding stents in the peripheral vasculature [PDF]

open access: yes, 2012
Background: A novel self-expanding drug-eluting stent was designed to release everolimus 225 mu g/cm(2) to prevent restenosis following peripheral arterial intervention.
Hausegger, Klaus A   +7 more
core   +2 more sources

Efficacy and Safety of a Novel Bioabsorbable Polymer-Coated, Everolimus-Eluting Coronary Stent: The EVOLVE II Randomized Trial

open access: yesCirculation. Cardiovascular Interventions, 2015
Background—Drug eluting stents with durable polymers may be associated with hypersensitivity, delayed healing, and incomplete endothelialization, which may contribute to late/very late stent thrombosis and the need for prolonged dual antiplatelet therapy.
Circ Cardiovasc Interv   +15 more
semanticscholar   +1 more source

Implantation of paclitaxel-eluting stents in saphenous vein grafts: clinical and angiographic follow-up results from a multicentre study. [PDF]

open access: yes, 2006
Objective: To define the clinical and angiographic follow-up results after implantation of paclitaxel-eluting stents (PESs) in stenotic saphenous vein grafts (SVGs). Design: Prospective multicentre study. Comparison with a control group.
Blindt, Ruediger   +5 more
core   +2 more sources

Identification of Hemodynamically Optimal Coronary Stent Designs Based on Vessel Caliber [PDF]

open access: yes, 2012
Coronary stent design influences local patterns of wall shear stress (WSS) that are associated with neointimal growth, restenosis, and the endothelialization of stent struts.
Gundert, Timothy J   +4 more
core   +1 more source

Quantification of Local Hemodynamic Alterations Caused by Virtual Implantation of Three Commercially Available Stents for the Treatment of Aortic Coarctation [PDF]

open access: yes, 2014
Patients with coarctation of the aorta (CoA) are prone to morbidity including atherosclerotic plaque that has been shown to correlate with altered wall shear stress (WSS) in the descending thoracic aorta (dAo).
Dholakia, Ronak Jashwant   +3 more
core   +2 more sources

Comparison of a Novel Biodegradable Polymer Sirolimus-Eluting Stent With a Durable Polymer Everolimus-Eluting Stent: Results of the Randomized BIOFLOW-II Trial

open access: yesCirculation. Cardiovascular Interventions, 2015
Background—Biodegradable polymers for release of antiproliferative drugs from drug-eluting stents aim to improve vascular healing. We assessed noninferiority of a novel ultrathin strut drug-eluting stent releasing sirolimus from a biodegradable polymer ...
S. Windecker   +19 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy